A research team from Nanyang Technological University, Singapore (NTU Singapore) and Tan Tock Seng Hospital (TTSH) have invented a smart handheld medical device that could enable early intervention for patients with congestive heart failure.
The portable innovation, which resembles a stethoscope, is made up of an acoustic sensor connected to a smartphone. It enables early intervention by allowing patients to check for excess fluid in the lungs at home. Fluid accumulation in the lungs, which causes breathlessness, is a common symptom of congestive heart failure.
One in five people worldwide run the risk of developing congestive heart failure, and this prevalence increases with age. As there is no cure for the ailment, patients can only monitor their health closely with lifestyle changes or medication to prevent their heart function from deteriorating irreversibly.
Currently, patients can only check for fluid accumulation in the lungs by going for a clinical examination, which can be considerably subjective, or through imaging modalities and serum biomarker tests, which are costly and take a longer time.
The non-invasive device built by a team led by NTU Associate Professor Ser Wee and TTSH Associate Professor David Foo circumvents these problems with its portability, ease of use and quick results. Currently a prototype, the device is able to detect any excess fluid in the lungs in 10 seconds once placed on the patient’s chest or back.
In a pilot study using lung sounds recorded from TTSH’s congestive heart failure patients, Assoc Prof Ser and his team found the device to have over 92 per cent accuracy in identifying patients with the condition – comparable to existing ‘gold standard’ diagnosis methods such as X-rays and CT scans. The findings were first presented at the 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
Associate Professor Foo, Head of Cardiology at TTSH, said, “Patients can monitor their condition at home and use the device whenever they feel slightly breathless at home. It is potentially a game-changer in the management of ambulatory heart failure patients. It can also provide a rapid and accurate acute diagnosis of heart failure in situations of undifferentiated shortness of breath symptoms.”
Associate Professor Ser from NTU’s School of Electrical and Electronic Engineering added, “Currently, such diagnosis can only be conducted through clinical examination, which cannot be made frequently. Our smart medical device can be used by anyone, anywhere and any number of times, which will enable the possibility of early intervention of congestive heart failure.
“The next wave of MedTech (medical technology) start-ups will see the massive proliferation of smart medical devices that rely on artificial intelligence (AI) and sensing technologies, such as the one we invented, and that will enable personalised self-assessment and screening of cardiopulmonary and other diseases, and revolutionise the way healthcare is managed in future.”
How it works
In congestive heart failure, the diseased or overworked heart ventricle is unable to pump out enough of the blood it receives from the lungs. This causes pressure to build up first in the heart, then in the veins and capillaries in the lungs. The pressure then pushes fluid back through the capillary walls and into the air sacs of the lungs.
As a result, when air passes through these fluid-filled air sacs, crackles can be heard from the lungs. Depending on the intensity, a crackle may sound like salt added to a hot pan, or Velcro being torn apart. Based on this principle, Prof Ser and his team found a unique set of features that can be used to identify characteristics of sounds unique to patients with fluid accumulation in the lungs. They then developed a proprietary AI algorithm capable of identifying and processing these signals to determine if there is fluid accumulation in the lungs.
The smart medical device developed by NTU and TTSH first picks up breathing sounds through a sound sensor. Through a mobile app, the sound signals are then sent to a server located in the cloud. The NTU-developed algorithm stored in the cloud then processes these sound signals, and the results are shown on the mobile app. This whole process takes about 10 seconds to complete.
Following two rounds of tests with samples collected from 86 patients, the team is now running a third round of tests on the device to further validate its sensitivity and specificity.
A major pharmaceutical company, a healthcare MNC and a local healthcare company have approached the team to explore the possibility of collaborations.
The Latest on: Congestive heart failure
via Google News
The Latest on: Congestive heart failure
- Gift of Life: ‘I knew I was dying,’ Oklahoma man needed a life-saving donationon November 26, 2021 at 3:35 am
News 4’s Jacklyn Chappell’s father will be sitting around the Thanksgiving table on Thursday with his family, celebrating a moment they weren’t sure would ever come: his first holiday with a new ...
- Long Island dad with heart problems offers cautionary tale about watching healthon November 22, 2021 at 2:25 pm
A dad on Long Island is sharing his story on the critical importance of getting the right doctors to check on your health.
- Can going to bed at 10 p.m. reduce heart disease risk?on November 22, 2021 at 4:02 am
We know that having sleep apnea doubles the risk of congestive heart failure and atrial fibrillation specifically and triples the risk of heart disease in general. People with restless leg syndrome ...
- AHA: Risk for Heart Disease Up for Young Black Adults in the U.S.on November 19, 2021 at 10:39 am
Young African American patients have had an increasing burden of cardiovascular disease (CVD) risk factors and worsened in-hospital outcomes, though with improved survival odds, according to a study ...
- TAVR provides alternative to open heart surgeryon November 18, 2021 at 2:00 am
Then came the final diagnosis — congestive heart failure. Doctors put in a stent as a temporary measure, but let Riffle know a more permanent treatment would be necessary. One of the doctors Riffle ...
- For smokers, fatal heart attack or stroke may be first sign of cardiovascular diseaseon November 17, 2021 at 3:07 pm
It's long been known that smoking greatly raises the risk for heart disease and stroke. But new research suggests the first sign a smoker is developing cardiovascular problems also may be the last.
- Florida Jury Awards $6M to Family Claiming Doctor Didn’t Treat Patient’s Failing Hearton November 16, 2021 at 7:45 am
Although records indicated that the doctor believed the patient's heart was failing, the defense’s experts opined that the patient did not exhibit symptoms of congestive heart failure.
- At 3% CAGR, Congestive Heart Failure (CHF) Treatment Devices Market Size Set to Register 5753.1 million USD by 2025on November 16, 2021 at 6:36 am
Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.0% in the forecast period of 2020 to 2025 and will expected to reach 5753.1 ...
- Men’s health awareness month: heart riskson November 15, 2021 at 9:42 pm
It’s not that uncommon that we see 40-year-olds presented in our emergency room with heart attacks, stroke, congestive heart failure,” said Dr. Bryan. “So I think it starts younger than what people ...
via Bing News